Metabolic syndrome in patients with childhood psoriasis
- Conditions
- Health Condition 1: L408- Other psoriasis
- Registration Number
- CTRI/2022/04/042199
- Lead Sponsor
- Pandit BD Sharma PGIMS Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Newly diagnosed patients of stable chronic plaque psoriasis in the age group of 10-18yrs
Children under age of 10 years
Adults more than 18 years
Patients with other skin diseases known to be associated with metabolic syndrome such as vitiligo, acanthosis nigricans, lichen planus, androgenetic alopecia and systemic lupus erythematosus.
Patients with history of smoking and alcoholism.
Patients receiving systemic therapy for psoriasis like systemic retinoids, immunosuppressants for at least 6 weeks and any topical therapy for 4 weeks prior to enrollment in the study.
Patients taking other medications known to cause hyperglycemia, hypertension and hyperlipidemia within 72 hours prior to enrollment in the study.
Patients with history of endocrine disease like cushing disease, acromegaly, phaeochromocytoma, hyperthyroidism, glucagonoma.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method